AmacaThera Overview
- Founded
- 2015

- Status
- Private
- Employees
- 11

- Latest Deal Type
- Series A
- Latest Deal Amount
- $8.89M

- Investors
- 16
AmacaThera General Information
Description
Developer of a hydrogel technology designed to enable sustained drug release. The company's technology offer a fast gelling material that liquefies under force and it is a reversible and fast gelling physical blend of hyaluronan (HA) and methylcellulose (MC), enabling doctors to help reduce patients' post-operative pain.
Contact Information
Website
Formerly Known As
Hammock Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
- 661 University Avenue
- Suite 1300
- Toronto, Ontario M5G 0B7
- Canada
+1 (647) 000-0000
AmacaThera Timeline
AmacaThera Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Early Stage VC (Series A) | 02-Nov-2020 | $8.89M | 000.00 | Completed | Generating Revenue | |
6. Seed Round | 03-Oct-2019 | 00.000 | 00.000 | Completed | Generating Revenue | |
5. Accelerator/Incubator | 01-Mar-2019 | 0000 | Completed | Generating Revenue | ||
4. Accelerator/Incubator | 0000 | 0000 | Completed | Startup | ||
3. Accelerator/Incubator | 0000 | Completed | Startup | |||
2. Accelerator/Incubator | 09-May-2016 | $50K | $50K | Completed | Startup | |
1. Accelerator/Incubator | Completed | Startup |
AmacaThera Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Michael Cooke Ph.D | Co-Founder, Board Member & Chief Executive Officer | ||
Molly Shoichet Ph.D | Co-Founder, Chief Scientific Officer & Board Member |
AmacaThera Board Members (4)
Name | Representing | Role | Since |
---|---|---|---|
Andrew Bishop | Self | Board Member | 000 0000 |
Michael Cooke Ph.D | AmacaThera | Co-Founder, Board Member & Chief Executive Officer | 000 0000 |
Molly Shoichet Ph.D | AmacaThera | Co-Founder, Chief Scientific Officer & Board Member | 000 0000 |
Peter Velden | AmacaThera | Board Member | 000 0000 |
AmacaThera Signals
Growth Rate

0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile

-35.5%.
530%
Size Multiple

219x
Median
Size Multiple
219x, 100th %ile

0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAmacaThera Investors (16)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
BDC Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
China Resources Capital Management | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
Inveready Technology Investment Group | Venture Capital | Minority | 000 0000 | 000000 0 | |
MaRS Investment Accelerator Fund | Venture Capital | Minority | 000 0000 | 000000 0 | |
StandUp Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |